Giraldo Pilar, Solano Victor, Pérez-Calvo Juan-Ignacio, Giralt Manuel, Rubio-Félix Daniel
Department of Hematology, Miguel Servet University Hospital, Zaragoza, Spain.
Qual Life Res. 2005 Mar;14(2):453-62. doi: 10.1007/s11136-004-0794-y.
The impact of type 1 Gaucher disease and its therapy on health-related quality of life (QOL) was investigated and the results were compared with a Spanish adult normative group.
Between January 1998 and December 2002, a prospective clinical QOL trial was conducted by application of a Spanish version of the Health Survey SF-36 questionnaire. Patients receiving ERT (69 cases) filled in the questionnaire two times, prior to starting ERT and after two years under ERT. The patients were stratified by gender and age group. Clinical and X-ray data to assess bone disease were obtained from the Spanish Gaucher Register. Demographic, clinical, genotype and analytical data and the response to therapy were evaluated. Four grades of severity were established according to bone disease (no symptoms = 0, moderate bone pain = 1, severe bone crisis = 2, fracture/necrosis = 3). Correlation analysis was made between QOL score and grade of bone disease.
Mean age+/-SD 33.6+/-11.7 (range 18-66), M/F,ratio 33/36; bone disease: 0 in 27 patients (47.3%), 1 in 11 (19.3%), 2 in 5 (8.8%) and 3 in 14 (24.5%). Physical activity: 11 patients (19.3%) showed severe restriction and 41 patients (71.9%) were only limited for strenuous activities. The mean score for QOL questionnaire was 11.9+/-10.4 (range 2-46). Correlation between score and bone disease was significant only for 1 and 3 grades (p = 0.02). Improvement in self perception of global health was observed ranging from 34.3% before ERT to 91.4% after ERT (p = 0.001). Nevertheless physical activity remained unsatisfactory in 24.5% of patients due mainly to bone sequelae.
Physical activities and bone disease grade 1 and 3 are negatively related to QOL. Nevertheless no correlation was found with bone pain crisis, possibly due to the transitory character of this event. In spite of the improvement induced by ERT, a quarter of patients remained with physical limitations related to bone disease as well as in need of orthopaedic correction of bone sequelae. In order to improve the QOL an accurate evaluation of bone disease to define therapeutic approaches must be considered.
研究了1型戈谢病及其治疗对健康相关生活质量(QOL)的影响,并将结果与西班牙成年正常人群组进行了比较。
1998年1月至2002年12月期间,通过应用西班牙文版的健康调查SF - 36问卷进行了一项前瞻性临床QOL试验。接受ERT治疗的患者(69例)在开始ERT治疗前和ERT治疗两年后两次填写问卷。患者按性别和年龄组进行分层。从西班牙戈谢病登记处获取评估骨病的临床和X线数据。评估人口统计学、临床、基因型和分析数据以及对治疗的反应。根据骨病情况确定了四个严重程度等级(无症状 = 0,中度骨痛 = 1,严重骨危象 = 2,骨折/坏死 = 3)。对QOL评分与骨病等级进行相关性分析。
平均年龄±标准差为33.6±11.7(范围18 - 66岁),男/女比例为33/36;骨病情况:27例患者(47.3%)为0级,11例(19.3%)为1级,5例(8.8%)为2级,14例(24.5%)为3级。身体活动情况:11例患者(19.3%)表现出严重受限,41例患者(71.9%)仅在剧烈活动时受限。QOL问卷的平均评分为11.9±10.4(范围2 - 46)。评分与骨病之间的相关性仅在1级和3级时显著(p = 0.02)。观察到整体健康自我认知的改善,从ERT治疗前的34.3%提高到ERT治疗后的91.4%(p = 0.001)。然而,24.5%的患者身体活动情况仍不理想,主要原因是骨后遗症。
身体活动以及骨病1级和3级与QOL呈负相关。然而,未发现与骨痛危象相关,可能是由于该事件的短暂性。尽管ERT治疗带来了改善,但四分之一的患者仍存在与骨病相关的身体限制以及需要对骨后遗症进行矫形。为了提高QOL,必须考虑对骨病进行准确评估以确定治疗方法。